Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood

被引:0
作者
Stimpfl, M
Schmid, BC
Obermair, A
Tong, D
Schiebel, I
Gitsch, G
Leodolter, S
Zeillinger, R
机构
[1] Univ Vienna, Dept Obstet & Gynecol, Div Gynecol, Mol Oncol Grp, A-1090 Vienna, Austria
[2] Ludwig Boltzmann Inst Gynaecol Oncol & Reprod Med, A-1090 Vienna, Austria
关键词
immunomagnetic separation; epithelial markers; evaluation of detection methods;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, there has been significant effort in developing techniques designed to detect disseminated tumor cells in the peripheral blood (PB). These techniques include immunocytochemical staining of cytocentrifuge slides, flow cytometry, and RT-PCR. Several authors reported various results concerning the sensitivity of the detection Limit when applying these methods. The aim of this study was to assess the value of two methods in the detection of ovarian carcinoma cells in the PB. For tumor cell detection we compared RT-PCR to immunomagnetic enrichment followed by flow cytometric analysis. In a model system, single cell suspensions of ovarian cancer cell lines were mixed with full blood samples from healthy donors in order to determine the sensitivity limit of the two methods and to analyze the reproducibility of each. In a multiparameter flow cytometric analysis, tumor cells were defined as cytokeratin 7/8 positive and CD45 negative. RNA was screened for MUC1 mRNA by RT-PCR. MUC1 mRNA expression turned out not to be a specific marker of disseminated ovarian cancer cells, because a weak expression was also found in samples of healthy persons. Using immunomagnetic enrichment followed by flow cytometry, one carcinoma cell per 1x10(6) leukocytes was detectable. However, a minimum of 10 ml blood had to be analyzed in order to clearly distinguish rear positive tumor cells from false-positive signals.
引用
收藏
页码:367 / 373
页数:7
相关论文
共 29 条
  • [1] Berois N, 1997, ANTICANCER RES, V17, P2639
  • [2] Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
    Bostick, PJ
    Chatterjee, S
    Chi, DD
    Huynh, KT
    Giuliano, AE
    Cote, R
    Hoon, DSB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2632 - 2640
  • [3] DETECTION OF EPITHELIAL CANCER-CELLS IN PERIPHERAL-BLOOD BY REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION
    BURCHILL, SA
    BRADBURY, MF
    PITTMAN, K
    SOUTHGATE, J
    SMITH, B
    SELBY, P
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 278 - 281
  • [4] BRCA2 germline mutations in male breast cancer cases and breast cancer families
    Couch, FJ
    Farid, LM
    DeShano, ML
    Tavtigian, SV
    Calzone, K
    Campeau, L
    Peng, Y
    Bogden, B
    Chen, Q
    Neuhausen, S
    ShattuckEidens, D
    Godwin, AK
    Daly, M
    Radford, DM
    Sedlacek, S
    Rommens, J
    Simard, J
    Garber, J
    Merajver, S
    Weber, BL
    [J]. NATURE GENETICS, 1996, 13 (01) : 123 - 125
  • [5] SENSITIVE DETECTION OF OCCULT BREAST-CANCER BY THE REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION
    DATTA, YH
    ADAMS, PT
    DROBYSKI, WR
    ETHIER, SP
    TERRY, VH
    ROTH, MS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) : 475 - 482
  • [6] Denis MG, 1997, INT J CANCER, V74, P540, DOI 10.1002/(SICI)1097-0215(19971021)74:5<540::AID-IJC11>3.0.CO
  • [7] 2-A
  • [8] Immunobead RT-PCR: A sensitive method for detection of circulating tumor cells
    Eaton, MC
    Hardingham, JE
    Kotasek, D
    Dobrovic, A
    [J]. BIOTECHNIQUES, 1997, 22 (01) : 100 - 105
  • [9] Putative markers for the detection of breast carcinoma cells in blood
    Eltahir, EM
    Mallinson, DS
    Birnie, GD
    Hagan, C
    George, WD
    Purushotham, AD
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (08) : 1203 - 1207
  • [10] ERCOLANI L, 1988, J BIOL CHEM, V263, P15335